Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients by Brisson Diane, Ledoux Karine, Bossé Yohan, St-Pierre Julie, Julien Pierre, Perron Patrice, Hudson Thomas J, Vohl Marie-Claude, Gaudet Daniel in Pharmacogenetics (2002).

[PMID: 12042669] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.